Amryt Pharma Share Discussion Threads

[whatno] 17/8/2021 10:03

I would expect more price support as we move into September. The Oleogel-s10 PDUFA date is on the horizon and there is a capital markets event on the 13th. The latter should allow Amryt to better get the message across as to the benefits of the Chiasma deal.

[papillon] 17/8/2021 09:46

Hi Adw198. The AMYT chart is gradually turning bullish again. I added Friday and yesterday. Once the sellers are out of the way on Nasdaq (be they ex Novelion shareholders, or shareholders of the company that AMYT is currently acquiring) then the AMYT ADS's should take off.

[adw198] 17/8/2021 08:47

Hi Papp, yes there were a few other little errors in the commentary but it’s possibly/probably broadly correct to recognise some of the Nasdaq sellers might be Americans who don’t want to be involved with a European company.

[papillon] 16/8/2021 12:34

Well AMYT is not a UK stock. It's an Irish company with it's primary listing on Nasdaq these days, where the majority of AMYT shares are held. AIM is only it's secondary listing.

[adw198] 15/8/2021 18:22

Another positive bit of coverage here, from about 26m 30s in.



There was reference to US investors not being willing or able to own UK stocks, suggesting the recent drop was Chiasma holders selling out. Not sure how accurate that is given the NASDAQ listing?

[papillon] 13/8/2021 20:08

The usual on Nasdaq. Opens up then the sellers appear. I wonder how long this situation will last?

[pdt] 13/8/2021 13:41

Bermuda - thanks, good to see you here. Hopefully, we have a good run here as Angle has had recently!

[bermudashorts] 13/8/2021 12:05

PDT - welcome!

[papillon] 13/8/2021 11:13

Yes, CWA1, that's because the pre market price of the ADS's on Nasdaq is up.

[cwa1] 13/8/2021 10:55

Perking up again...

[pdt] 12/8/2021 17:53

After watching the Amati video I did some research and dipped a toe in here today.

The NASDAQ page was interesting to see price targets ranging from $29 to $40 which is a leap from the $10 currently.

It does seem that the next six months could be interesting. I assume a rerate could happen with the potential FDA approval being the catalyst by November. As always time will tell. A revenue guidance increase in September will be interesting but I doubt will move the price much.

[richpassi] 12/8/2021 12:57

Is it going to be a 2.30 start again today ?

[papillon] 11/8/2021 22:37

AMYT closed fractionally down on Nasdaq on big volume. There are still sellers around in the States. Not too worried as we could be on the start of an uptrend.

Here's a couple of Nasdaq ADS charts if anyone is interested. One showing Heikin-Ashi candlesticks (good for showing trends) and an Ichimoku chart (it's still strongly bearish, but that could soon change).





And here's an AIM chart showing Heikin-Ashi candlesticks


free stock charts from uk.advfn.com

[digadee] 11/8/2021 21:55

From LSE - thanks bermudaAmati fund manager, Dr Paul Jourdan talks about his portfolio in the link below and discusses Amryt at about 37.50 - well worth a listenhxxps://www.youtube.com/watch?v=eYObwUdaKpE

[papillon] 11/8/2021 16:22

I agree with you Bermudashorts. Those Ex Novelion shareholders have taken the opportunity of selling the ADS's they received from the liquidator of Novelion having been in limbo for almost 2 years.

PS SupeARich should have realised that AMYT would have had to issue an RNS if a major shareholder had "offloaded" over 10%.

[patient fox] 11/8/2021 16:16

I think the vox interview helped today.

[bermudashorts] 11/8/2021 16:00

I assume he's referring to the TR1 yesterday showing Athyrium's % holdings falling from 24% to 14% but as you have pointed out, this is simply a reflection of the additional shares in issue following the Chiasma acquisition. Their holding has actually remained the same.

The reason for the downturn over recent months is highly likely to be down to the distribution of over 2m AMYT ADRs by Novelion's liquidator back in March. Hopefully that's all washed through now and we'll see a good recovery into news due in H2.

IMO etc.

[digadee] 11/8/2021 15:49

Suparich, are you getting confused with investors over 3% having to adjust their holding information due to the issue of new shares?

[bermudashorts] 11/8/2021 15:33

Which major shareholder has sold over 10% of AMYT?

[cwa1] 11/8/2021 14:56

Seem to be "off to the races" this afternoon

[paleje] 11/8/2021 11:18

Change in sentiment Stateside consistent with last comments, see link below, 187% upside according to one broker:-

[papillon] 11/8/2021 09:57

free stock charts from uk.advfn.com


Look at the very high volumes on Nasdaq, richpassi, when the acquisition was announced on the 5th May and the when the results were issued on Friday. Was Friday the final sell off day? There is a bit of life in the AMYT Ichimoku chart, but it's still strongly bearish. I have a feeling that the AMYT ADS's bottomed on Friday.

PS I might be a day out. It could have been Thursday, the day before the results were announced, that the ADS price fell on huge volume.

[richpassi] 11/8/2021 07:58

I was watching it last night and it did seem to be waking up a bit and after our recent purchases it's welcomed :) Bring on the charts ;)

[papillon] 11/8/2021 07:19

Better late than never, richpassi. Is the tide turning for AMYT on Nasdaq? I think it is. I'll post an ADS chart later showing volume.